|
m.3303C>T突变引起线粒体心肌病一例及文献复习
|
Abstract:
目的:报告1例由m.3303C>T突变引起MCM的患儿的临床表现以及诊断过程,以提高对该病的临床认识以及早期诊断。方法:回顾分析1例于我科确诊的MCM患儿的临床资料,通过高通量测序技术获得突变基因信息,采用Sanger法验证突变位点,最终确诊本病。结果:男性患儿6个月,发现心脏杂音就诊,行心超提示心肌肥厚,考虑心肌病。患儿入院后完善基因检测提示m.3303C>T纯质性变异,为已报道的疑似致病变异。该例患儿在治疗期间心肌呈进行性增大,心功能下降迅速,半年后死亡。结论:由m.3303C>T突变引起线粒体心肌病的患儿病情进展较迅速,如不明原因心脏增大/心肌肥厚的患儿就诊,建议完善线粒体环基因检测协助明确病因,排除线粒体心肌病可能。
Objective: A case of mitochondrial cardiomyopathy caused by the m.3303C>T mutation was reported to improve the clinical understanding and early diagnosis of the disease. Methods: Retrospective analysis of the clinical data of a child diagnosed with MCM in our department. Mutation gene information was obtained using high-throughput sequencing technology, and the mutation site was verified by the Sanger method, which ultimately confirmed the disease. Results: A six-month-old boy was found to have a heart murmur and was diagnosed with myocardial hypertrophy through echocardiography, suggesting cardiomyopathy. Genetic testing after admission indicated a m.3303C>T homoplasmic variation, which is a reported suspected pathogenic variant. During the treatment, the myocardium of the child was progressively enlarged, with the cardiac function decreasing rapidly. This child died six months later. Conclusions: Children with mitochondrial cardiomyopathy caused by the m.3303C>T mutation have rapid progression. If children present with unexplained cardiac enlargement/myocardial hypertrophy, the mitochondrial genetic examination may help us to diagnose the cause of cardiomyopathy and rule out the possibility of mitochondrial cardiomyopathy.
[1] | Craven, L., Alston, C.L., Taylor, R.W. and Turnbull, D.M. (2017) Recent Advances in Mitochondrial Disease. Annual Review of Genomics and Human Genetics, 18, 257-275. https://doi.org/10.1146/annurev-genom-091416-035426 |
[2] | Hsu, P., Chu, C., Lin, T., Lu, Y., Lee, C., Lai, W., et al. (2008) Adult-Onset Hypertrophic Cardiomyopathy Manifested as Initial Major Presentation of Mitochondrial Disease with A-to-G 3243 tRNA Leu(uur) Point Mutation. International Journal of Cardiology, 129, 441-443. https://doi.org/10.1016/j.ijcard.2007.06.098 |
[3] | Kisler, J.E., Whittaker, R.G. and Mcfarland, R. (2010) Mitochondrial Diseases in Childhood: A Clinical Approach to Investigation and Management. Developmental Medicine & Child Neurology, 52, 422-433. https://doi.org/10.1111/j.1469-8749.2009.03605.x |
[4] | Holmgren, D. (2003) Cardiomyopathy in Children with Mitochondrial Disease Clinical Course and Cardiological Findings. European Heart Journal, 24, 280-288. https://doi.org/10.1016/s0195-668x(02)00387-1 |
[5] | Scaglia, F., Towbin, J.A., Craigen, W.J., Belmont, J.W., Smith, E.O., Neish, S.R., et al. (2004) Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients with Mitochondrial Disease. Pediatrics, 114, 925-931. https://doi.org/10.1542/peds.2004-0718 |
[6] | Levinger, L., Oestreich, I., Florentz, C. and Mörl, M. (2004) A Pathogenesis-Associated Mutation in Human Mitochondrial Trnaleu(uur) Leads to Reduced 3’-End Processing and CCA Addition. Journal of Molecular Biology, 337, 535-544. https://doi.org/10.1016/j.jmb.2004.02.008 |
[7] | Silvestri, G., Santorelli, F.M., Shanske, S., Whitley, C.B., Schimmenti, L.A., Smith, S.A., et al. (1994) A New mtDNA Mutation in the Trnaleu(uur) Gene Associated with Maternally Inherited Cardiomyopathy. Human Mutation, 3, 37-43. https://doi.org/10.1002/humu.1380030107 |
[8] | Bruno, C., Kirby, D.M., Koga, Y., Garavaglia, B., Duran, G., Santorelli, F.M., et al. (1999) The Mitochondrial DNA C3303T Mutation Can Cause Cardiomyopathy and/or Skeletal Myopathy. The Journal of Pediatrics, 135, 197-202. https://doi.org/10.1016/s0022-3476(99)70022-3 |
[9] | Lev, D., Nissenkorn, A., Leshinsky-Silver, E., Sadeh, M., Zeharia, A., Garty, B., et al. (2004) Clinical Presentations of Mitochondrial Cardiomyopathies. Pediatric Cardiology, 25, 443-450. https://doi.org/10.1007/s00246-003-0490-7 |
[10] | Assomull, R.G., Prasad, S.K., Lyne, J., Smith, G., Burman, E.D., Khan, M., et al. (2006) Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy. Journal of the American College of Cardiology, 48, 1977-1985. https://doi.org/10.1016/j.jacc.2006.07.049 |
[11] | Meyers, D.E., Basha, H.I. and Koenig, M.K. (2013) Mitochondrial Cardiomyopathy: Pathophysiology, Diagnosis, and Management. The Texas Heart Institute Journal, 40, 385-394. |
[12] | Pompei, M. and Pompei, F. (2018) Overcoming Bioethical, Legal, and Hereditary Barriers to Mitochondrial Replacement Therapy in the Usa. Journal of Assisted Reproduction and Genetics, 36, 383-393. https://doi.org/10.1007/s10815-018-1370-7 |
[13] | Tarnopolsky, M.A., Roy, B.D. and MacDonald, J.R. (1997) A Randomized, Controlled Trial of Creatine Monohydrate in Patients with Mitochondrial Cytopathies. Muscle & Nerve, 20, 1502-1509. https://doi.org/10.1002/(sici)1097-4598(199712)20:12<1502::aid-mus4>3.0.co;2-c |